Pregnancy

This COVID-19 roundup includes coverage of the latest and final COVID-19 treatment guidelines by the NIH, the effectiveness of the COVID-19 vaccine in preventing pediatric long COVID, the spring 2024...

Researchers examined the characteristics and trends related to the increased mortality rates associated with overdose in pregnant and postpartum women.

The CDC reported more than 200,000 cases of syphilis in 2022, a 17% increase compared with the previous year. In response, the CDC provided new recommendations for testing syphilis in the laboratory.

In a single-group trial, researchers assessed the safety and risks associated with interrupting endocrine therapy for women with stage I, II, or III breast cancer attempting pregnancy.

Researchers aimed to quantify the amount of protection maternal COVID-19 boosters provide during the first 6 months of an infant’s life.

The US Preventive Task Force (USPSTF) expanded upon their previous recommendations on screening for hypertensive disorders, including gestational hypertension, in patients who are pregnant.

Researchers sought to find an association and prevalence of hepatitis C infection during pregnancy using data from 1998 to 2018.

Earlier this year, the FDA approved the same vaccine for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.

The FDA has approved the first daily oral contraceptive for the prevention of pregnancy that does not require a health care provider’s prescription.